MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Abiomed Appoints Dr. Charles Simonton as Chief Medical Officer
June 15, 2020—Abiomed, maker of the Impella heart pump, announced it has appointed Charles Simonton, MD, as Vice President and Chief Medical Officer.
Sponsored by Abiomed, Inc.
The Opportunity for Increased Quality Care and Shared Savings With the Impella® Heart Pump
By Charles Simonton, MD
CMS Approves New Technology Add-On Payment for Abbott Vascular's MitraClip
August 5, 2014—Abbott Vascular advised that the US Center for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment for the company’s MitraClip transcatheter mitral valve repair system while maintaining the device within its current diagnosis-related group classification.
Xience V (Promus) Drug-Eluting Coronary Stent
Design features, preclinical data, and clinical outcomes.
By Krishna Sudhir, MD, PhD, FRACP, FACC; David R. Rutledge, Pharm D, FAHA, FCCP; Alena Pechonkina, MD; and Chuck Simonton, MD, FACC, FSCAI
Medicare NCD Expands Access to Abbott's MitraClip System
August 12, 2014—Abbott Vascular announced that the US Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination (NCD) that extends coverage for Medicare beneficiaries in the United States to transcatheter mitral valve repair with Abbott’s MitraClip system.
